Regeneron Pharmaceuticals (REGN) total liabilities

Total liabilities · fiscal 2025
$9.30B

Regeneron Pharmaceuticals (REGN) had total liabilities of $9.30B at the end of fiscal 2025 (December 31, 2025). That is 10.7% higher than the $8.41B of fiscal 2024. Figures as of 18 Nov 2026, 18:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$9.30B
Change on fiscal 2024
+10.7%
Growth, 5 years
+8.7% a year
Growth, 10 years
+16.9% a year
Highest on record
$9.30Bfiscal 2025
Lowest on record
$344.44Mfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Regeneron Pharmaceuticals total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 8.7% a year; over ten years the rate was 16.9% a year. Across the 17 fiscal years on record (2009–2025), the highest was $9.30B in fiscal 2025 and the lowest $344.44M in fiscal 2009.

History · 17 fiscal years

Total liabilities by fiscal year

Regeneron Pharmaceuticals total liabilities, year by year

Regeneron Pharmaceuticals (REGN) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$9.30B 10.7% up
2024$8.41B 18.3% up
2023$7.11B 8.5% up
2022$6.55B 1.7% down
2021$6.67B 8.6% up
2020$6.14B 65.2% up
2019$3.72B 24.8% up
2018$2.98B 13.6% up
2017$2.62B 3.8% up
2016$2.52B 29.2% up
2015$1.95B 51.8% up
2014$1.29B 28.9% up
2013$998.94M 19.6% up
2012$835.11M 0.3% down
2011$837.85M 49.2% up
2010$561.62M 63.1% up
2009$344.44M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Regeneron Pharmaceuticals and comparable companies
CompanyTotal liabilitiesFiscal year
Moderna MRNA$3.69B2025
CVS Health CVS$178.16B2025
HCA Healthcare HCA$63.49B2025
GSK GSK£45.16B2025
Regeneron Pharmaceuticals REGN$9.30B2025
Elevance Health ELV$77.47B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on REGN

Regeneron Pharmaceuticals, figure by figure

Regeneron Pharmaceuticals (REGN) overview: price, valuation and scorecardAll health care companies by market value

Regeneron Pharmaceuticals total liabilities: questions and answers

How large are Regeneron Pharmaceuticals's total liabilities?

Regeneron Pharmaceuticals (REGN) had total liabilities of $9.30B at the end of fiscal 2025 (December 31, 2025). That is 10.7% higher than the $8.41B of fiscal 2024.

What is the growth rate of Regeneron Pharmaceuticals's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 8.7% a year; over ten years the rate was 16.9% a year.

What are the highest and lowest total liabilities figures on record for Regeneron Pharmaceuticals?

Across the 17 fiscal years on record (2009–2025), the highest was $9.30B in fiscal 2025 and the lowest $344.44M in fiscal 2009.

How is Regeneron Pharmaceuticals's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Regeneron Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regeneron Pharmaceuticals (REGN) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/REGN/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.